We are live on ! Find out more
CK

Cohen Klingenstein Portfolio holdings

AUM $3.49B
1-Year Est. Return 26.65%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+26.65%
3 Year Est. Return
+87.7%
5 Year Est. Return
+104.29%
10 Year Est. Return
+422.19%
AUM
$2.92B
AUM Growth
+$52.9M
Cap. Flow
-$270K
Cap. Flow %
-0.01%
Top 10 Hldgs %
61.82%
Holding
220
New
Increased
6
Reduced
90
Closed
13

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$49.7M
2
NVDA icon
NVIDIA
NVDA
+$35.8M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$27M
4
UNP icon
Union Pacific
UNP
+$19.6M
5
PEP icon
PepsiCo
PEP
+$15M

Sector Composition

Rank Sector Weight
1 Technology 14.89%
2 Communication Services 8.24%
3 Financials 8.19%
4 Healthcare 7.4%
5 Consumer Discretionary 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXN icon
76
Texas Instruments
TXN
$255B
$4.11M 0.14%
21,900
UPS icon
77
United Parcel Service
UPS
$89.5B
$3.66M 0.13%
29,049
-129
-0.4% -$17K
VZ icon
78
Verizon
VZ
$193B
$3.62M 0.12%
90,641
T icon
79
AT&T
T
$159B
$3.53M 0.12%
154,832
SI
80
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$3.46M 0.12%
35,800
TGT icon
81
Target
TGT
$65.6B
$3.45M 0.12%
25,505
-7,185
-22% -$1.03M
VOT icon
82
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
$3.42M 0.12%
13,490
+170
+1% +$43.8K
MET icon
83
MetLife
MET
$62.5B
$3.38M 0.12%
41,245
-3,000
-7% -$250K
LIN icon
84
Linde
LIN
$235B
$3.35M 0.11%
8,000
-5,000
-38% -$2.28M
GSK icon
85
GSK
GSK
$104B
$3.32M 0.11%
98,198
-6,114
-6% -$220K
KO icon
86
Coca-Cola
KO
$381B
$3.24M 0.11%
52,000
-49,200
-49% -$3.21M
ABBV icon
87
AbbVie
ABBV
$455B
$3.2M 0.11%
18,000
-32,500
-64% -$5.98M
ADP icon
88
Automatic Data Processing
ADP
$105B
$3.13M 0.11%
10,705
CARR icon
89
Carrier Global
CARR
$50.6B
$3.12M 0.11%
45,668
-11,614
-20% -$876K
LOW icon
90
Lowe's Companies
LOW
$118B
$2.95M 0.1%
11,950
-10,100
-46% -$2.7M
TJX icon
91
TJX Companies
TJX
$176B
$2.85M 0.1%
23,600
COP icon
92
ConocoPhillips
COP
$145B
$2.83M 0.1%
28,500
-3,000
-10% -$319K
MS icon
93
Morgan Stanley
MS
$330B
$2.74M 0.09%
21,800
BSX icon
94
Boston Scientific
BSX
$68.4B
$2.72M 0.09%
30,500
GEN icon
95
Gen Digital
GEN
$16.3B
$2.7M 0.09%
98,600
BMY icon
96
Bristol-Myers Squibb
BMY
$132B
$2.69M 0.09%
47,559
-21,000
-31% -$1.17M
GEV icon
97
GE Vernova
GEV
$262B
$2.68M 0.09%
8,143
MO icon
98
Altria Group
MO
$113B
$2.68M 0.09%
51,203
-245
-0.5% -$13.1K
MCD icon
99
McDonald's
MCD
$191B
$2.61M 0.09%
9,000
-12,400
-58% -$3.7M
DE icon
100
Deere & Co
DE
$162B
$2.54M 0.09%
6,000

Similar funds

Cohen Klingenstein's Q4 2024 Portfolio in Review

As of Q4 2024, Cohen Klingenstein held 220 positions worth $2.92B, up 1.8% from $2.87B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Cohen Klingenstein's Q4 2024 filing shows 6 increased, 90 reduced and 13 closed positions. The largest sale was Apple, an estimated $49.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Communication Services and Financials.

  • Cohen Klingenstein added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $286M increase.
  • Cohen Klingenstein's biggest Q4 2024 reduction was Apple, cutting an estimated $49.7M.
  • Cohen Klingenstein fully exited Intuit in Q4 2024, selling an estimated $12.8M.
  • Cohen Klingenstein's ten largest holdings make up 62% of its $2.92B portfolio in Q4 2024.
  • Cohen Klingenstein opened 0 new positions and closed 13 in Q4 2024.
  • Cohen Klingenstein's portfolio value rose 1.8% quarter-over-quarter to $2.92B.

Based on Cohen Klingenstein's 13F filing for Q4 2024, filed 15 Jan 2025.